The global market for hyaluronic acid in healthcare is set to grow from $8 billion in 2025 to $10.5 billion by 2030, with a CAGR of 5.7%. The report covers various medical applications of HA, including dermal fillers and regenerative wound care, and highlights trends like sustainable production methods and increasing R&D in new medical fields.

Key drivers of the market’s growth include expanding clinical applications of HA, innovations in biotechnology leading to safer and more effective products, and a trend towards minimally invasive procedures. These factors are reshaping the competitive landscape and driving the adoption of HA in various medical fields.

In the U.S., over 90% of injectable aesthetics products are imported, highlighting the global nature of the market. HA’s ability to bind to specific receptors in inflammatory and tumor settings enables targeted delivery. Additionally, HA is being used in 3D bioprinting for creating living structures like skin and blood vessels.

Emerging startups like Evolus Inc. and BioRegen Biomedical are making waves in the HA market with innovative technologies for dermal fillers and wound repair. The report answers key questions about the market size, growth rate, segment dominance, and key players in the industry.

Market leaders in the hyaluronic acid medical products space include AbbVie, Bioventus, and Galderma, among others. The report also mentions related reports on medical aesthetic devices and provides information on how to purchase a copy of the report directly from BCC Research.

BCC Research’s market research reports aim to provide unbiased analysis and assessment of market opportunities, helping businesses make informed decisions. For media inquiries or access to the market research library, visit the media page on the BCC Research website or contact them via email.

Read more at GlobeNewswire: Global Hyaluronic Acid in Healthcare Market to Reach $10.5